Study to Evaluate the Effects of Single Ascending Oral Doses of ACD856 on Safety, Tolerability and Pharmacokinetics

NCT05077631 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Cognition Disorder

Interventions

DRUG: ACD856
DRUG: Placebo
DRUG: ACD856 (fed cohort)

Sponsor

AlzeCure Pharma